| | Sham | C | R | VD | R + VD |
|---|
| |
 |
 |
 |
 |
 |
Four-point scale (point) | 0.75 ± 1.5 | 0.7 ± 0.8 | 0.4 ± 0.5 | 1.3 ± 1.9 | 2.3 ± 1.6 |
RUST (point) | 8.4 ± 1.4 | 8.0 ± 1.0 | 7.4 ± 1.3 | 6.7 ± 1.3 | 7.9 ± 0.9 |
- Sham, sham group; C, control group; R, romosozumab group; VD, active vitamin D3 group; and R + VD, romosozumab + active vitamin D3 group. The fracture line was clear in the C group. In contrast, fracture lines were unclear in the R group, VD group, and R + VD group, whereas abundant callus formation was observed for the R and R + VD groups. No significant differences were observed in the four-point test and RUST scores between the groups
